All manuscripts must be submitted electronically through our website available at “Submit Paper” menu.
Submit text files only in .DOC or .DOCX file formats ― other file formats are not accepted.
Authors are required to email or upload any permission that may have been obtained for figures or tables, or any permission required for patient consent after they have received the official acceptance letter.
Accepted Manuscript Types
The APJCP accepts the following manuscript types:
Research Articles: Scientific reports of original research. The text for research articles is limited to 5,000 words including the title page, abstract, text, references, figures, and tables.
Review Articles including mini-review: A timely, in-depth treatment of an issue. Review articles are generally solicited by the editors, but unsolicited materials may also be considered. Authors intending to submit a review article must send an email in this regard to the Editor-in-Chief at firstname.lastname@example.org with the subject line of “Request to send a review for APJCP”. The author must also explain his intent and present supporting documents of his/her competency in the subject. His request will be assessed and he/she will be notified of the results of the editorial assessment, and then he may proceed accordingly.
Systematic Review and Meta-analysis: A systematic review answers a defined research question by collecting and summarizing all empirical evidence that fits pre-specified eligibility criteria. A meta-analysis is the use of statistical methods to summarize the results of these studies.
Methodological papers: Manuscripts containing a description of novel methods and significant improvements to tried-and-tested basic research techniques related to cancer are welcomed. The manuscript has to provide readers with new tools and skills to improve their methodology and/or conduct their research.
Editorials: Opinions of recognized leaders in cancer specialties. Editorials are generally solicited by the Editor-in-Chief and are related to a manuscript on the same issue. The length should not exceed 2,400 words and with no more than 20 references.
Commentaries: Presents a point of view of general interest not related to an article in the same issue of the APJCP.
Short Communications: Brief notes on selected topics from recognized cancer organizations such as the Asian Pacific Organization for Cancer Prevention. The length should not exceed 2,000 words and with no more than 2 tables and figures, and no more than 20 references.
In Memoriam: Memorialization of recently deceased individuals who have made notable contributions to the field of cancer prevention in the Asia pacific region.
Correspondence: Letters to the Editor related to papers previously published in the APJCP. Letters must be submitted within six months of the online publication date of the article. The authors of the original publication will be given the opportunity to respond in the same issue of the journal. Letters and responses must not exceed 750 words in length. Financial associations or other potential conflicts of interest must be declared.
Case series: Reports of single cases will not be considered; however, the APJCP encourages large case series from Asian countries/populations (minorities, ethnicities, and populations with a particular attribute), in which not much data on cancer is available.
Protocol:Manuscript of ongoing or starting large well-designed studies such as clinical trials and cohorts can be considered for publication if the manuscript follows the Protocol Items for Randomized Trials (SPIRIT)) articulation. Prospective authors are advised to visit the SPIRIT site at "http://www.spirit-statement.org" and read the convention and prepare their manuscript using the SPIRTI recommendations. The manuscript should present all items listed in the SPIRTI checklist. The protocol must have ethical approval and be officially registered (for clinical trials) before being considerd for publication.
The APJCP does not charge any submission, page, or colour fees. However, to defray costs of formatting and PubMed linkage, there is presently a 200US$ publication charge for accepted manuscripts. Extra fees may be charged as necessary for lengthy/numerous/complex tables and/or figures.
Due to the high volume of submissions we receive, the APJCP does not consider pre-submission inquiries. Instead, please submit full manuscripts online.
APOCP’s Cancer Control Conviction
The APJCP will not consider any work that is funded directly or indirectly by tobacco companies or their subsidiaries. Any such work will be editorially rejected. Please note that this does not include work from organizations that sponsor research from funds won as part of tobacco settlements that are intended to promote research and care toward alleviating the suffering of individuals affected by tobacco products.
Simultaneous Submission and Online Posting
The APJCP will not consider manuscripts that are concurrently submitted elsewhere or have been published previously (including online publications). The presentation of research results at scientific conferences or in the abstract book of the conference does not constitute a previously published article. A manuscript cannot be posted on the author’s or institutional website when it has been submitted to the APJCP EMMS. Accepted manuscripts cannot be posted online until after the paper has been fully published in the APJCP.
Cell Line Authentication
To ensure the highest standards of quality and accuracy, the APJCP strongly encourages the authentication of cell lines used in the research submitted to the journal. Manuscripts based on research using cell lines must include a statement addressing the following points in the Methods section of the manuscript:
Where the cells were obtained from.
Whether the cell lines have been tested and authenticated.
The method by which the cells were tested.
If cells were obtained directly from a cell bank that performs cell line characterizations and had a passage in the user’s laboratory for fewer than 6 months after receipt or resuscitation, re-authorization is not required. In these cases, please include the method of characterization used by the cell bank. If the cell lines were obtained from an alternate source, authors must provide authentication of the origin and identity of the cells. This is best achieved by DNA (STR) profiling. The DNA profile should be cross-checked with the DNA profile of the donor tissue (in the case of a new cell line), or with the DNA profile of other continuous cell lines.
Clinical Trial Registry
The APJCP requires that all prospective, randomized, controlled trials be registered in a national or international registry such as:
Reports of Randomized Controlled Trials (RCTs) must clearly state the method of randomization. The title and abstract must specify that the manuscript is a report of randomized controlled trials. Authors reporting RCTs manuscript are advised to provide the CONSORT checklist as a supplemental file (download a copy of the CONSORT checklist).
The authors’ names listed in a manuscript indicate that each author have participated sufficiently in the work to take public responsibility for the content. Authorship should be established based on the following criteria and responsibilities:
Substantial contributions to conception and design, or analysis and interpretation of research.
Participate critically in revising intellectual contents of the paper.
Author has approved the final version of the paper.
Accept responsibility for all aspects of the work.
Author status must carefully be reviewed prior to submitting a manuscript. Changes to the names on the author list (adding or deleting) may not be permitted or may require extra charges for corresponding authors.
Authors' Professional and Ethical Responsibilities
The APJCP reserves the right to forward any claim of scientific misconduct to the sponsoring or funding institution, or to other appropriate authorities for investigation ― the APJCP does not investigate or make determinations of misconduct. The author will be notified if the APJCP forwards any manuscript to the sponsoring or funding institution for such a claim.
Permission to use copyrighted materials
Use of previously published or copyrighted material reproduced from another source must be properly cited. The corresponding author is responsible for obtaining written permission from the appropriate authors and/or copyright holders to use previously published or copyrighted material. Signed permission statements from the copyright holder for both print and online reproduction, must be sent to the APJCP Editorial Office upon manuscript submission. Permission statements must also be obtained from at least one author when citing in press articles.
Observational studies (cohort, case-control, or cross-sectional designs) must be reported according to the STROBE Statement. Authors reporting Observational studies are advised to provide the STOBE Statement as a supplemental file (download a copy of the STOBE statement).
Reports of Diagnostic Tests
Authors reporting diagnostic tests studies are advised to provide the STARD flow diagram and checklist as a supplemental file (download a STARD Follow Diagram).
The following guidelines should be followed:
Report the effective sample size for each study and each subgroup analysis.
Describe the power analysis to justify the sample size if appropriate.
Identify all statistical methods and verify the assumptions for all statistical tests.
Provide alpha (the probability of a Type I error) for all statistical tests.
Specify whether tests are one- or two-sided.
Report the descriptive statistics (n, mean, median, and standard deviation) for all continuous variables.
Adequately explain complex statistical procedures such a multivariate logistic regression and the Cox proportional hazard regression model, and verify the assumptions of each such procedure.
Report the actual P-values and explain what is meant by statistical significance.
Classification and Staging
In reporting clinical staging of cancer UICC TNM Classification and Stage groupings should be used. If another staging system is stated, UICC TNM equivalent must also be provided. When a stage or classification is used in the manuscript, a reference citing the staging system must be provided.
Drugs and Devices
Use the generic drug name (or generic name followed by trade name in parentheses). Include manufacturer and their location (city and country) for drugs and devices.
Use only standard abbreviations and spell out all abbreviations at first use in the text, followed by the abbreviation in parentheses.
Protection of Human and Animal Subjects
The APJCP endorses the principles governing the protection of human subjects in research embodied in the Declaration of Helsinki and expects that all investigations involving human subject have been performed in accordance with these principles.
Use the following standard when appropriate to report data and information:
Cancer Staging: UICC TNM Classification of Malignant Tumors.
Histological classification of tumors: International Calcification of Disease Oncology (ICD-O) from the international disease calcification system of the World Health Organization.
Drug naming: Both generic and brand name.
Chemical terms: Naming and Indexing of Chemical Substances for Chemical Abstracts.
Terms relating to diseases, operations, and procedures: Use the International Classification of Diseases (ICD) of the World Health Organization.
Units of measure: Use Systéme International (SI) or metric system.
REQUIRED INFORMATION, FILES AND FORMATING GUIDELINES
Submission to journal includes:
1) ّّّّFilling out the metadata form
When you submit your manuscript, you need to have the following items of information ready:
Corresponding author’s contact information: You need to provide the complete contact information of the corresponding author including e-mail, phone number, institutional address.
Running Head: Prepare a running head of 40 characters or less for your manuscript.
Abstract: Prepare an abstract of your manuscript according to the author’s guideline. Normally Research Articles, Review Articles, Meta-analysis, and case series, should include an abstract.
Keywords: Prepare three to ten keywords. Keywords are used for optimizing search engines ― appropriate keywords are therefore important.
Co-authors Information: For a successful upload, you need to have the full name, affiliation, and emails of all authors.
Candid reviewer: During manuscript submission, you are asked to candid at least one reviewer for your manuscript. You need to have the name, affiliation, and email for one reviewer. Make sure the reviewer of your choice is competent in the subject of your manuscript.
2)uploading your files
You need to have at least two files prepared for uploading: the cover Letter, the manuscript.Both files must be either Microsoft Word, OpenOffice, or PDF file. If you have supplementary or supporting data (SSD) files you can upload it at this stage of submission.
How to prepare the files:
Please read carefully and prepare your files (especially the manuscript file) as instructed here. The manuscript that does not follow the format, will be returned to the author before undergoing any screening or review process.
The Cover Letter
A cover letter is a simple letter to the editor with the corresponding author’s signature. The cover letter contains two parts: 1) A statement that the work has not been published or is currently under review for publication in another journal, and 2) A very brief (not more than three sentences) explanation of the significance and novelty of the work and the problem that is being addressed.
Your manuscript is a single file (a text file with embedded figures, tables etc.). You may either prepare your manuscript using a word processing program and save it as a .doc or .rtf file, remembering to insert your figures and tables into the document.
A typical manuscript includes the following items:
Title page (including title, author’s name, author's affiliation, address and contact info, all disclosure and support statements).
Keywords (at least 3 to 10 keywords).
The body of the manuscript with headings of Introduction, Material and Methods, Results, and Discussion.
The following items are required on the title page:
Running title: A short version of the title (up to 40 characters including spaces).
Each author's name, academic degrees, and affiliation.
Complete mailing address, telephone, fax, and e-mail for corresponding authors.
Any disclosure (conflict of interest disclosure).
A Research Article, Systematic Review and Meta-analysis, Methodological Paper, and Case Series, must each contain a structured abstract of approximately 300 words. The structured abstract must have four specified subtitles: Background, Methods, Results, and Conclusion(s). Abstracts are not required for Editorials, Commentaries, Short Communications, or Correspondence.
Three to 10 keywords or terms to be used as index terms. Use terms from the medical subject headings list of nlm.nih.gov/mesh. The keywords are listed after the abstract on the same page.
Body of the manuscript:
The body of the manuscript should be divided into four sections: (Introduction, Material and Methods, Results, and Discussion). The Materials and Methods and Results section can have sub-headings based on author’s choice (no subheading for Introduction and Discussion). The section headings and sub-headings should be typed on a separate line. While the body does not contain a conclusion heading, the last paragraph of the discussion will state the study’s conclusion.
It is very important to cite the references according to the journal rules and format. A manuscript that does not follow the reference citation of the journal, will be returned to the author before undergoing any review or initial screening. References citations must be provided as follows:
Citation in the text:
Rule # 1) If you report the name of the author in the text, cite as “Yellow (2000)”. For example; As Yellow (2000) reported in his previous work ― please note that just the LAST NAME of the first author is used.
Rule # 2) If the name of the author is not part of the text, follow these rules:
References with one author should be cited as (Last name, year) such as “It has been reported(Yellow, 2000)”.
References with two authors should be cited in the text as (Last name of the first author and last name of the second author followed by a comma and then the year, such as (Brown and Pink, 2000). Please note that the LAST NAMEs of both authors are used.
References with more than two authors should be cited in the text as (last name of the first author with et al., followed by a comma and then the year) such as (Black et al., 2000). Please note that only the LAST NAMEs are used ― no initial(s) or first name.
If more than one reference is used for the same data or information, the references should be chronologically listed and separated by a semi- colon such as (Yellow et al., 1995; Red et al., 2010). Rule # 2 applies to references between semi-colons, separated by semi-colons.
In the reference list:
Rule # 1) List references in alphabetical order of the first author’s last name (surname).
Rule # 2) If two or more references have the same author, the list should be organized based on author’s name and year of publication (references of the same author must be listed sequentially with the earlier publication listed first).
Rule # 3) Provide the names of all authors if there are 5 or fewer authors.
Rule # 4) If there are more than 5 authors, provide the names of the first three authors, followed by et al.,
Rule # 5) In writing the names of the authors, the rule is to use the last name and then the initials for the first and/or middle names. No period or space between the initials: For example, (Blue AB, Pink B, Green CJ, et al (2000).
Rule # 6) The volume number has to be in bold face.
Rule # 7) in writing the name of the journal, the rule is to use the standard abbreviation of the Journal’s name. You can download an Excel file that contains abbreviation for many journals so that you can check if you have the right abbreviation for the journals’ name.
For Journals: Author’s name according to the reference list rules 1 to 5, then TITLE followed by YEAR inside the parenthesis, followed by the standard abbreviation of the journal name, volume number (in bold), followed by starting page, then – ending page. The ending page should be just the last digit: 322-24 or 322-324 is wrong ― 322-4 is the correct use in this case.
An example for journal: Blue A, Pink B, Green C, et al (2000). TITLE. Asian Pac J Cancer Prev, Volume, 322-4.
For Books: The same formatting rules for name and page numbering. A book reference should include (Authors, book title, chapter title, publisher’s name and address, and page number).
An example for a book: Brown A, Pink B, Black CD, et al (2000). Cancer Prevention. In 'Neoplasia', Eds Blue D and Red E. Asian Pacific Education Press, Bangkok pp 1-10 Numbers 322-4
Important notice: We encourage authors to use a reference management system, and develop or obtain a journal style, and then format the references. You can find EndNote style for the journal by clicking here.
Try not to use references that are not standard or references that are not registered in international registration systems such as non-English publications that do not provide an English citation format.
A manuscript may include an “Acknowledgment” section. The acknowledgment section should be on a separate page after the references section. In this section, authors acknowledge all contributions from other persons, funding agencies, and any individual or organization who have contributed to the research that was done, or in the compilation of the manuscript, etc.
Tables should be formatted as single-spaced on separate pages in the word processing program. The following guidelines need to be adhered to in preparing tables:
Tables imported into the word-processing program from spreadsheet programs (e.g., Microsoft Excel), should be left in table format and not converted to text. Gridlines should be retained and the spreadsheet file should be provided as well).
Do not embed tables as graphic files.
Limit the number of tables to three and try to avoid redundancy of findings in different tables.
Cite all tables in the text. Number tables consecutively, using Arabic numerals, in the order cited in the text. The table number is followed by a brief descriptive title.
Include table number, ‘‘continued,’’ and table sub-headings on each page if a table exceeds one manuscript page.
Define all abbreviations used in the table in footnotes to the table.
Obtain written permission to reproduce the previously published tabular material. Credits for the reproduced work are included as a footnote to the table and must include author(s), title, either publisher and city/ country, or periodical name, volume, page, and year. Signed permission forms must be sent to the Editorial Office upon acceptance.
The following guidelines need to be adhered to in preparing figures and legends:
Submit only publication quality high-resolution figures.
The following resolutions are required: 1200 dpi for line art; 300 dpi for halftones/color (RGB); 600 dpi for combination halftones/color.
Figures should be sized to either one-column width (19 picas, 3.25 inches), or two-column width (40 picas, 6.75 inches), as appropriate.
Figures must be numbered in the text. Number all figures sequentially with Arabic numerals in the order cited in the text.
Provide double-spaced legends on a separate page to include the figure number and a brief description of the figure.
For typeface within figures, use 6-pt to 12-pt Times or Times New Roman font.
Figures with multiple parts should be labeled and referred to as (a), (b), (c), etc.
Obtain written permission to reproduce previously published figures. Credits for the reproduced work are included in the figure legend and must include author(s), title, either publisher’ city and country or periodical name, volume, page, and year. Signed permission forms must be sent to the APJCP Editorial Office upon submission.
Embed each figure in a Microsoft PowerPoint slide and upload as a separate file.
Mask any patient identification in photographs; otherwise, a signed permission statement is required.
Supplement and Supporting Data(SSD)
Supplement and supporting data (SSD) will be published and uploaded as a linkable file in the online version of the article. SSD is mentioned in the article text and published online in its original format, along with the article. SSD will undergo peer review with the rest of the manuscript, but will not be copy-edited or changed from its original format. It must be relevant, but not integral to the paper. It may contain additional tables, data sets, figures, movie files, audio clips, 3D structures, and other related nonessential multi-media files. Like the manuscript accompanying it, it should be original and not previously published. If previously published, it must be submitted with the necessary permissions.
The names and email addresses entered into this journal site will be used exclusively for the stated purposes of this journal, and will not be made available for any other purpose or to any other party.
To submit your paper, You need to register first then submit your paper.